To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNHIT1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
459 supporting clones for gene ZNHIT1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP367860 thymus .a 1 to 571 1 to 570   tiling clone,   570/570
(100 %)
4 diff
(99.3 %id)
BE745976 adenocarcinoma cell line, ovary .a 56 to 643 1 to 586       586/590
(99 %)
5 diff
(99.2 %id)
BX107548 ovarian tumor, ovary .a 60 to 783 1 to 725   tiling clone,   725/725
(100 %)
1 diff
(99.9 %id)
AA437327 ovarian tumor, ovary .a 60 to 483 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
AI734107 ovarian tumor, ovary .a 60 to 551 1 to 492       492/492
(100 %)
0 diff
(100 %id)
AA443544 ovarian tumor, ovary .a 65 to 470 1 to 402       402/402
(100 %)
2 diff
(99.6 %id)
AA356835   .a 117 to 387 1 to 272       272/272
(100 %)
1 diff
(99.7 %id)
AW960283   .a 118 to 582 1 to 463       463/463
(100 %)
12 diff
(97.5 %id)
AA443545 ovarian tumor, ovary .a 516 to 883 367 to 1   tiling clone,   367/370
(99 %)
2 diff
(99.5 %id)
DB096262 testis .b 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
AK125123 tongue, tumor tissue .b 3 to 4190 1 to 4184 exact tiling clone, available from FLJ,   4184/4184
(100 %)
12 diff
(99.8 %id)
DA459586 tongue, tumor tissue .b 4 to 507 2 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
AW876795 pnet .b 1190 to 1679 509 to 20   tiling clone,   490/518
(94 %)
0 diff
(100 %id)
BF843053 head_neck .b 1527 to 1764 238 to 1   tiling clone, Submitted on the opposite strand 238/238
(100 %)
0 diff
(100 %id)
BI017402 lung_tumor .b 1540 to 1723 187 to 4       184/187
(98 %)
0 diff
(100 %id)
AA078461 placenta .b 1618 to 1833 1 to 216       216/216
(100 %)
2 diff
(99.1 %id)
BF529819 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2102 to 2748 1 to 648   available from MGC,   648/648
(100 %)
62 diff
(90.5 %id)
AA076828 brain .b 2164 to 2286 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
BM808951 brain, hippocampus .b 2517 to 3286 37 to 810   tiling clone,   774/1015
(76 %)
17 diff
(98.4 %id)
TI_57182001   .b 2517 to 2965 46 to 492   AAA   447/975
(45 %)
12 diff
(98.8 %id)
BE745158 adenocarcinoma cell line, ovary .b 2524 to 3320 1 to 807       807/906
(89 %)
74 diff
(91.9 %id)
AA077070 brain .b 2695 to 2875 181 to 1       181/181
(100 %)
0 diff
(100 %id)
AI083841 anaplastic oligodendroglioma, brain .b 3383 to 3692 310 to 1       310/310
(100 %)
0 diff
(100 %id)
AI366663 anaplastic oligodendroglioma, brain .b 3383 to 3689 307 to 1       307/307
(100 %)
0 diff
(100 %id)
AI571204 anaplastic oligodendroglioma, brain .b 3383 to 3689 307 to 1       307/307
(100 %)
0 diff
(100 %id)
DB314502 tongue, tumor tissue .b 3646 to 4190 545 to 1       545/545
(100 %)
0 diff
(100 %id)
BC010454 Brain, anaplastic oligodendroglioma with1p/19q loss .c 1 to 2896 1 to 2896 exact tiling clone, available from MGC, AAA   2896/2896
(100 %)
2 diff
(100.0 %id)
AK092478 placenta .c 332 to 2395 1 to 2063   available from FLJ,   2063/2063
(100 %)
4 diff
(99.9 %id)
DA843543 placenta .c 333 to 893 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA907048   .c 1029 to 1593 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BG678937 skin, squamous cell carcinoma .c 1646 to 2184 1 to 540       540/542
(99 %)
2 diff
(99.7 %id)
BG698294 skin .c 1724 to 2506 1 to 778       776/778
(99 %)
15 diff
(98.1 %id)
BG697272 skin .c 1741 to 2644 1 to 902   tiling clone,   902/904
(99 %)
17 diff
(98.2 %id)
BG999844 head_normal .c 1758 to 2143 403 to 21       383/403
(95 %)
0 diff
(100 %id)
DB328542 placenta .c 1844 to 2395 553 to 1       553/553
(100 %)
2 diff
(99.7 %id)
AA328859   .c 2039 to 2432 1 to 399       399/399
(100 %)
5 diff
(98.8 %id)
BQ920241 carcinoma, cell line, Prostate .d 1 to 910 1 to 915   tiling clone,   915/1021
(89 %)
28 diff
(97.3 %id)
BQ437464 melanotic melanoma, skin .d 28 to 801 1 to 793       789/948
(83 %)
27 diff
(97.2 %id)
BG473763 eye, retinoblastoma .d 36 to 737 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
BC017333 Eye, retinoblastoma .d 37 to 1223 1 to 1187 exact tiling clone, available from MGC, AAA   1187/1187
(100 %)
1 diff
(100.0 %id)
NM_006349.2   .d 37 to 1223 1 to 1187 exact RefSeq, AAA   1187/1187
(100 %)
0 diff
(100 %id)
T47448 placenta .d 43 to 396 1 to 360       360/361
(99 %)
10 diff
(97.3 %id)
CX788485 human embryonic stem cells .d 45 to 869 1 to 825       825/825
(100 %)
0 diff
(100 %id)
AV653754 corresponding non cancerous liver tissue .d 55 to 771 1 to 716     Submitted on the opposite strand 716/745
(96 %)
10 diff
(98.7 %id)
BE730769 choriocarcinoma, placenta .d 56 to 891 1 to 832       832/1143
(72 %)
22 diff
(98.1 %id)
BE734187 choriocarcinoma, placenta .d 57 to 776 1 to 720       720/724
(99 %)
5 diff
(99.4 %id)
CX869230 embryonic stem .d 57 to 662 1 to 606   fully sequenced,   606/606
(100 %)
2 diff
(99.7 %id)
BU162759 melanotic melanoma, cell line, skin .d 68 to 880 1 to 828       826/915
(90 %)
24 diff
(97.4 %id)
BI859089 breast, mammary adenocarcinoma, cell line .d 114 to 928 1 to 813       813/813
(100 %)
9 diff
(98.9 %id)
TI_57188046   .d 114 to 928 52 to 864       813/813
(100 %)
9 diff
(98.9 %id)
BC001877 Placenta, choriocarcinoma .d 159 to 1223 1 to 1066 N83K F84L Q85S A86G L87P ... available from MGC, AAA   1066/1066
(100 %)
3 diff
(99.8 %id)
BE278265 choriocarcinoma, placenta .d 177 to 859 1 to 683   available from MGC,   683/683
(100 %)
9 diff
(98.7 %id)
BU161276 melanotic melanoma, skin .d 229 to 1065 1 to 847 G98C Q145X R148X C149V L150S ...     847/895
(94 %)
18 diff
(98.0 %id)
TI_149302742   .d 427 to 1223 850 to 63 V2E E3N K4S K5F T6A ... AAA   788/941
(83 %)
11 diff
(98.9 %id)
AA156383 Pancreas .d 470 to 794 1 to 326       326/334
(97 %)
12 diff
(96.5 %id)
BM980886 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 480 to 1223 759 to 19 V2G K4E K5N T6S S7F ... AAA   741/741
(100 %)
5 diff
(99.4 %id)
CB125103 Liver .d 488 to 1136 1 to 649 L88S     649/649
(100 %)
2 diff
(99.7 %id)
AK312136 cerebellum .d 492 to 993 1 to 502 N92K     502/502
(100 %)
1 diff
(99.9 %id)
BU600356 mixed (pool of 40 RNAs) .d 492 to 1192 1 to 707 exact     707/751
(94 %)
11 diff
(98.6 %id)
BP330557 rectum .d 492 to 1078 1 to 587 T6A     587/587
(100 %)
1 diff
(99.9 %id)
DA104265 cerebellum .d 493 to 1034 2 to 543 exact capped   542/542
(100 %)
0 diff
(100 %id)
DA932609 Spleen .d 497 to 1068 2 to 573 exact capped   572/572
(100 %)
0 diff
(100 %id)
CB110893 Liver .d 498 to 1068 1 to 571 exact     571/571
(100 %)
0 diff
(100 %id)
BF792955 adrenal cortex carcinoma, cell line, adrenal gland .d 499 to 1200 1 to 700 exact     700/700
(100 %)
2 diff
(99.8 %id)
U61837   .d 499 to 1223 1 to 725 exact     725/725
(100 %)
1 diff
(99.9 %id)
CD048899 embryonic stem cells, WA01, passage 38 .d 503 to 1223 18 to 737 C128R Y135N AAA   720/737
(97 %)
9 diff
(98.8 %id)
BQ071066 brain, neuroblastoma, cell line .d 503 to 1223 1 to 720 exact AAA   720/720
(100 %)
1 diff
(99.9 %id)
AL701885 human skeletal muscle .d 505 to 920 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BU595525 mixed (pool of 40 RNAs) .d 505 to 1163 1 to 664 exact     664/710
(93 %)
9 diff
(98.8 %id)
BQ678327 melanotic melanoma, cell line, skin .d 506 to 1223 1 to 717 T6L S7R R9A S10P Q11R ... AAA   717/717
(100 %)
38 diff
(94.8 %id)
BU599308 mixed (pool of 40 RNAs) .d 508 to 1216 1 to 711 exact     711/815
(87 %)
13 diff
(98.5 %id)
BG756657 B-cells, primary B-cells from tonsils (cell line) .d 509 to 1222 1 to 716 K68T K69E K70E T71N R72P ... AAA   716/716
(100 %)
4 diff
(99.5 %id)
BG755877 B-cells, primary B-cells from tonsils (cell line) .d 509 to 1222 1 to 713 L88V     713/735
(97 %)
4 diff
(99.5 %id)
BI459861 testis .d 509 to 1046 1 to 538 exact     538/538
(100 %)
5 diff
(99.1 %id)
BM010002 amelanotic melanoma, cell line, skin .d 509 to 1205 1 to 697 exact     697/697
(100 %)
1 diff
(99.9 %id)
AA308779 colon .d 510 to 722 1 to 213       213/213
(100 %)
0 diff
(100 %id)
BG832002 epithelioid carcinoma cell line, Pancreas .d 510 to 1219 1 to 713 V154A     713/825
(86 %)
6 diff
(99.3 %id)
BI837018 pooled pancreas and spleen .d 510 to 1223 1 to 716 exact AAA   716/716
(100 %)
4 diff
(99.5 %id)
TI_57164049   .d 510 to 1224 36 to 752 exact AAA   717/752
(95 %)
11 diff
(98.6 %id)
TI_59384791   .d 510 to 1205 62 to 757 exact     696/696
(100 %)
0 diff
(100 %id)
DN994169 brain, whole brain .d 510 to 1147 27 to 664 exact     638/664
(96 %)
6 diff
(99.1 %id)
CD049117 embryonic stem cells, WA01, passage 38 .d 511 to 1224 10 to 721 V2W E3R K4R K5N T6F ...     712/734
(97 %)
9 diff
(98.8 %id)
CD387390 embryonic trophoblasts, made from WA01 stemcells .d 511 to 1223 19 to 729 V2W E3R K4R K5N T6F ... AAA   711/729
(97 %)
6 diff
(99.2 %id)
BG676319 skin, squamous cell carcinoma .d 511 to 1222 1 to 712 exact     712/868
(82 %)
1 diff
(99.9 %id)
CB111536 Liver .d 511 to 1136 1 to 625 exact     625/625
(100 %)
2 diff
(99.7 %id)
CB135292 Liver .d 511 to 1143 1 to 633 exact     633/633
(100 %)
0 diff
(100 %id)
BM686751 eye, optic nerve .d 511 to 1002 1 to 492 T6L S7R V8F R9A S10P ... fully sequenced,   492/492
(100 %)
7 diff
(98.6 %id)
DA521072 brain .d 512 to 1074 2 to 564 exact capped   563/563
(100 %)
0 diff
(100 %id)
CB109926 Liver .d 512 to 1009 1 to 498 exact     498/498
(100 %)
0 diff
(100 %id)
CB136514 Liver .d 513 to 952 1 to 440       440/440
(100 %)
1 diff
(99.8 %id)
AU107070   .d 514 to 563 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
BP204378 coronary artery .d 514 to 1097 1 to 584 K4T     584/586
(99 %)
6 diff
(99.0 %id)
BP215697 corpus callosum .d 514 to 1021 1 to 507 T6L S7R V8F R9A S10P ...     507/511
(99 %)
3 diff
(99.5 %id)
DB471102 hippocampus .d 514 to 996 1 to 477 V2G R17G I28Y N29Q P56A ...     477/478
(99 %)
18 diff
(96.3 %id)
N45376 placenta .d 514 to 974 1 to 465       465/614
(75 %)
10 diff
(98.4 %id)
BF967415 brain, hypothalamus .d 514 to 1223 6 to 713 Q113S R114A F116S C117V A118L ... AAA   708/713
(99 %)
18 diff
(97.5 %id)
BI252247 hepatocellular carcinoma, cell line, Liver .d 514 to 1223 1 to 707 P109H S110R R111G Q113S R114A ... fully sequenced,   707/707
(100 %)
10 diff
(98.6 %id)
BI596973 brain, hypothalamus .d 514 to 1074 6 to 565 exact     560/565
(99 %)
7 diff
(98.8 %id)
TI_45208881   .d 514 to 1074 95 to 654 exact     560/654
(85 %)
7 diff
(99.0 %id)
CB108045 Liver .d 514 to 996 1 to 483 exact     483/483
(100 %)
0 diff
(100 %id)
CB110166 Liver .d 514 to 1009 1 to 496 exact     496/496
(100 %)
1 diff
(99.8 %id)
CB109698 Liver .d 514 to 1007 1 to 494 K53R Q145X     494/494
(100 %)
1 diff
(99.8 %id)
CB113139 Liver .d 514 to 649 1 to 136       136/136
(100 %)
0 diff
(100 %id)
BP316881 pericardium .d 514 to 1096 1 to 583 exact     583/583
(100 %)
0 diff
(100 %id)
BP318532 pericardium .d 514 to 1095 1 to 583 exact     583/583
(100 %)
1 diff
(99.9 %id)
BQ082825 stomach .d 514 to 918 1 to 405       405/405
(100 %)
0 diff
(100 %id)
BG656021 Pancreas, Purified pancreatic islet .d 515 to 1043 10 to 538 exact     529/538
(98 %)
6 diff
(98.9 %id)
DA580335   .d 515 to 1070 2 to 559 Q41P D42G D43* capped   558/558
(100 %)
7 diff
(98.8 %id)
AA424497   .d 515 to 913 1 to 395   fully sequenced,   395/395
(100 %)
4 diff
(99.0 %id)
BI828922 brain, medulla .d 515 to 1225 1 to 710 exact     710/852
(83 %)
4 diff
(99.6 %id)
TI_57172738   .d 515 to 1225 70 to 779 exact     710/921
(77 %)
10 diff
(99.0 %id)
CB110638 Liver .d 515 to 966 1 to 452       452/452
(100 %)
2 diff
(99.6 %id)
DB004505 breast, tumor tissue .d 515 to 1072 2 to 559 exact capped   558/558
(100 %)
0 diff
(100 %id)
CD048217 embryonic stem cells, WA01, passage 38 .d 516 to 1224 21 to 727 V2W E3R K4R K5N T6F ...     707/921
(76 %)
8 diff
(99.2 %id)
BF130089 hypernephroma, Kidney .d 516 to 1190 1 to 661 E97R G98A P99L N100T Y101T ...     661/816
(81 %)
21 diff
(97.5 %id)
BF678081 Prostate .d 516 to 1223 1 to 702 R26V R27A I28S N29T R30G ... AAA   702/702
(100 %)
45 diff
(93.6 %id)
BM809298 amelanotic melanoma, cell line, skin .d 516 to 1224 1 to 708 V2W E3R K4R K5N T6F ... AAA   708/708
(100 %)
8 diff
(98.9 %id)
BQ072159 brain, neuroblastoma, cell line .d 516 to 1222 1 to 706 exact     706/711
(99 %)
2 diff
(99.8 %id)
BU196177 melanotic melanoma, cell line, skin .d 516 to 1225 1 to 709 T6L S7R V8F R9A S10P ...     709/709
(100 %)
5 diff
(99.3 %id)
BU157443 melanotic melanoma, cell line, skin .d 516 to 1223 1 to 709 exact     709/911
(77 %)
3 diff
(99.7 %id)
BQ679846 melanotic melanoma, cell line, skin .d 516 to 1222 1 to 706 T6L S7R V8F R9A S10P ...     706/713
(99 %)
2 diff
(99.8 %id)
BU174229 melanotic melanoma, cell line, skin .d 516 to 971 1 to 457   AAA   457/683
(66 %)
6 diff
(99.2 %id)
BG900904 cartilage .d 518 to 1100 40 to 622 C149R V154A     583/623
(93 %)
12 diff
(98.1 %id)
CN368312 embryonic stem cells, DMSO-treated H9 cellline .d 518 to 1045 4 to 531 exact     528/531
(99 %)
6 diff
(98.9 %id)
CR597071 Placenta Cot 25-normalized .d 519 to 1225 1 to 707 exact     707/707
(100 %)
0 diff
(100 %id)
BX357575 Placenta Cot 25-normalized .d 519 to 956 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
AW772663 hepatic adenoma, Liver .d 519 to 769 1 to 251       251/352
(71 %)
5 diff
(98.6 %id)
BG831940 epithelioid carcinoma cell line, Pancreas .d 519 to 1224 1 to 706 exact     706/870
(81 %)
3 diff
(99.7 %id)
BQ063662 lymph, lymphoma, cell line .d 519 to 1223 1 to 704 T6L S7R V8F R9A S10P ... AAA   704/704
(100 %)
8 diff
(98.9 %id)
TI_57242736   .d 519 to 1207 30 to 719 K67N     690/720
(95 %)
12 diff
(98.4 %id)
CB108270 Liver .d 519 to 945 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
BF685450 leiomyosarcoma cell line, uterus .d 520 to 883 466 to 823       358/893
(40 %)
30 diff
(96.7 %id)
BI914108 brain .d 520 to 1207 1 to 689 K67N     689/690
(99 %)
6 diff
(99.2 %id)
BM712356 eye, lens .d 520 to 752 1 to 233   fully sequenced,   233/233
(100 %)
1 diff
(99.6 %id)
BU174993 epidermoid carcinoma, cell line, salivary gland .d 521 to 1225 24 to 727 T6L S7L V8F R9A S10P ...     704/730
(96 %)
8 diff
(99.0 %id)
BG163970 hypernephroma, cell line, Kidney .d 523 to 1225 11 to 710 R9A S10L Q11P D12G G14R ...     700/868
(80 %)
26 diff
(97.1 %id)
BU178266 melanotic melanoma, skin .d 523 to 1086 74 to 638 T6L S7R V8F R9A S10P ...     565/1148
(49 %)
19 diff
(98.4 %id)
CB107967 Liver .d 523 to 956 1 to 434       434/434
(100 %)
3 diff
(99.4 %id)
BG180241 adenocarcinoma, cell line, Prostate .d 524 to 1223 1 to 700 exact AAA   700/700
(100 %)
5 diff
(99.3 %id)
BF343994 brain, glioblastoma with EGFR amplification .d 525 to 1117 26 to 616 F58L D59M D60T D61M A62R ...     591/625
(94 %)
12 diff
(98.1 %id)
BG122123 adenocarcinoma, cell line, Liver .d 525 to 1225 1 to 700 exact AAA   700/717
(97 %)
11 diff
(98.5 %id)
BG474680 eye, retinoblastoma .d 525 to 1195 1 to 671 P112X     671/897
(74 %)
11 diff
(98.8 %id)
BG171299 hypernephroma, cell line, Kidney .d 526 to 1225 1 to 690 Q113S R114A F116S C117V A118L ... AAA   690/704
(98 %)
14 diff
(98.1 %id)
CR992801 T-Lymphocytes .d 526 to 1223 1 to 698 exact AAA   698/698
(100 %)
0 diff
(100 %id)
BF727178 eye, lens .d 527 to 1023 1 to 497 exact     497/497
(100 %)
0 diff
(100 %id)
AA394206 ovarian tumor, ovary .d 527 to 878 1 to 352   fully sequenced,   352/352
(100 %)
3 diff
(99.2 %id)
AA378078 synovial membrane .d 528 to 801 1 to 276       276/320
(86 %)
3 diff
(99.1 %id)
BE389352 endometrium, adenocarcinoma cell line, uterus .d 528 to 1222 1 to 697 L88X AAA   697/697
(100 %)
13 diff
(98.2 %id)
BM803838 leiomyosarcoma, uterus .d 528 to 1127 1 to 616 Q145X R148Q C149V L150S K151E ...     616/1010
(60 %)
29 diff
(97.2 %id)
BQ876679 sympathetic trunk .d 528 to 1200 1 to 679 T6L S7R V8F R9A S10P ...     679/990
(68 %)
15 diff
(98.5 %id)
CR456992   .d 529 to 989 1 to 461       461/465
(99 %)
1 diff
(99.8 %id)
EL735240 mixed .d 529 to 992 1 to 464       464/623
(74 %)
1 diff
(99.9 %id)
BE733106 choriocarcinoma, placenta .d 529 to 1223 1 to 695 exact AAA   695/695
(100 %)
0 diff
(100 %id)
BM809325 amelanotic melanoma, cell line, skin .d 529 to 1224 1 to 694 T6L S7R V8F R9A S10P ...     694/694
(100 %)
2 diff
(99.8 %id)
BM807959 amelanotic melanoma, cell line, skin .d 529 to 1145 1 to 613 T6L S7R V8F R9A S10P ...     613/683
(89 %)
9 diff
(98.7 %id)
BM912918 amelanotic melanoma, cell line, skin .d 529 to 1219 1 to 690 T6L S7R V8F R9A S10P ...     690/1085
(63 %)
6 diff
(99.5 %id)
BM916367 amelanotic melanoma, cell line, skin .d 529 to 1097 1 to 569 exact     569/1034
(55 %)
1 diff
(100.0 %id)
CB159022 Liver .d 529 to 1007 1 to 479 exact     479/479
(100 %)
0 diff
(100 %id)
DA666308   .d 529 to 1063 2 to 536 exact capped   535/535
(100 %)
0 diff
(100 %id)
BM793381 Ascites, stomach .d 529 to 1005 1 to 477 P112S S130I R148T     477/477
(100 %)
3 diff
(99.4 %id)
AV704366 adrenal gland .d 530 to 1118 1 to 590       590/591
(99 %)
8 diff
(98.7 %id)
BE731718 choriocarcinoma, placenta .d 530 to 1100 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
BG179721 adenocarcinoma, cell line, Prostate .d 530 to 1225 1 to 701       701/752
(93 %)
13 diff
(98.3 %id)
CN368305 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 531 to 959 13 to 441       429/441
(97 %)
6 diff
(98.7 %id)
BG748556 eye, normal pigmented retinal epithelium .d 531 to 1221 1 to 701       701/727
(96 %)
14 diff
(98.1 %id)
BG768658 melanotic melanoma, high MDR (cell line), skin .d 531 to 1230 1 to 703       703/723
(97 %)
7 diff
(99.1 %id)
BI859688 breast, mammary adenocarcinoma, cell line .d 531 to 1223 1 to 695   AAA   695/695
(100 %)
3 diff
(99.6 %id)
BM922962 leukocyte .d 531 to 1224 10 to 704       695/715
(97 %)
8 diff
(98.9 %id)
BU160701 melanotic melanoma, skin .d 531 to 1224 27 to 720   AAA   694/720
(96 %)
10 diff
(98.7 %id)
TI_57189024   .d 531 to 1223 48 to 742   AAA   695/695
(100 %)
3 diff
(99.6 %id)
TI_59391005   .d 531 to 1222 100 to 791       692/725
(95 %)
1 diff
(99.9 %id)
BG479737 choriocarcinoma, placenta .d 532 to 1208 1 to 680       680/936
(72 %)
10 diff
(99.0 %id)
BG576171 breast, mammary adenocarcinoma, cell line .d 532 to 1225 1 to 695       695/715
(97 %)
2 diff
(99.8 %id)
BM020224 astrocytoma grade IV, cell line, brain .d 532 to 1222 1 to 691       691/724
(95 %)
1 diff
(99.9 %id)
BE249971 adenocarcinoma cell line, colon .d 533 to 1224 1 to 705       705/895
(78 %)
21 diff
(97.7 %id)
BE293383 adenocarcinoma cell line, colon .d 533 to 1191 677 to 16       662/677
(97 %)
0 diff
(100 %id)
BQ675534 epidermoid carcinoma, cell line, salivary gland .d 533 to 1223 1 to 690   AAA   690/690
(100 %)
8 diff
(98.9 %id)
BQ653165 hepatocellular carcinoma, cell line, Liver .d 533 to 1223 1 to 691   AAA   691/691
(100 %)
2 diff
(99.8 %id)
BU508289 leiomyosarcoma, uterus .d 533 to 1223 1 to 689   AAA   689/689
(100 %)
7 diff
(99.0 %id)
TI_57147611   .d 533 to 1128 21 to 622       602/1015
(59 %)
17 diff
(98.4 %id)
BE293683 adenocarcinoma cell line, colon .d 534 to 1147 1 to 609       609/686
(88 %)
8 diff
(98.9 %id)
BE732734 choriocarcinoma, placenta .d 534 to 1194 1 to 661       661/662
(99 %)
1 diff
(99.9 %id)
TI_43960333   .d 534 to 1223 52 to 744   AAA   693/744
(93 %)
12 diff
(98.4 %id)
BE047672 brain, tumor, 5 pooled (see description) .d 535 to 1016 1 to 482       482/482
(100 %)
0 diff
(100 %id)
BE902948 choriocarcinoma, placenta .d 535 to 1207 1 to 673       673/673
(100 %)
0 diff
(100 %id)
BM826155 Ascites, stomach .d 535 to 906 1 to 372       372/372
(100 %)
0 diff
(100 %id)
CN368311 embryonic stem cells, DMSO-treated H9 cellline .d 536 to 922 1 to 387       387/387
(100 %)
3 diff
(99.3 %id)
BE394045 endometrium, adenocarcinoma cell line, uterus .d 536 to 1225 1 to 687       687/688
(99 %)
9 diff
(98.7 %id)
AW410920 muscle, rhabdomyosarcoma .d 537 to 832 6 to 301   fully sequenced,   296/301
(98 %)
6 diff
(98.1 %id)
BG326643 Kidney, renal cell adenocarcinoma .d 537 to 1232 1 to 696       696/881
(79 %)
5 diff
(99.5 %id)
TI_57191619   .d 537 to 1225 85 to 773       689/693
(99 %)
1 diff
(99.9 %id)
TI_59394125   .d 537 to 1192 89 to 744       656/656
(100 %)
0 diff
(100 %id)
BQ637152 eye, retina .d 538 to 959 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
CN481474 eye .d 538 to 1143 1 to 607       607/607
(100 %)
5 diff
(99.2 %id)
BG329131 eye, retinoblastoma .d 538 to 1223 1 to 682   AAA   682/751
(90 %)
6 diff
(99.3 %id)
BG329045 eye, retinoblastoma .d 538 to 1191 1 to 651       651/653
(99 %)
9 diff
(98.7 %id)
BG825954 muscle, rhabdomyosarcoma .d 538 to 1223 1 to 686   AAA   686/686
(100 %)
2 diff
(99.8 %id)
BI862382 breast, mammary adenocarcinoma, cell line .d 538 to 1225 1 to 688       688/692
(99 %)
1 diff
(99.9 %id)
BM016505 breast, mammary adenocarcinoma, cell line .d 538 to 1192 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BY796271 eye .d 539 to 1098 1 to 560       560/560
(100 %)
0 diff
(100 %id)
T81208 liver and spleen .d 539 to 599 1 to 61       61/62
(98 %)
1 diff
(98.4 %id)
R09894 liver and spleen .d 539 to 702 1 to 163       163/169
(96 %)
5 diff
(97.1 %id)
AA418128 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 539 to 1110 1 to 572       572/572
(100 %)
4 diff
(99.4 %id)
BE744837 adenocarcinoma cell line, ovary .d 539 to 1224 1 to 686       686/779
(88 %)
3 diff
(99.7 %id)
BF796271 lymph, lymphoma, cell line .d 539 to 1192 1 to 653       653/923
(70 %)
7 diff
(99.3 %id)
BG030630 breast, mammary adenocarcinoma, cell line .d 539 to 1223 1 to 685   AAA   685/685
(100 %)
2 diff
(99.8 %id)
BG283974 adenocarcinoma, cell line, Prostate .d 539 to 1143 1 to 609       609/609
(100 %)
4 diff
(99.4 %id)
BI713143 Pancreas, Purified pancreatic islet .d 539 to 1146 18 to 625       608/625
(97 %)
0 diff
(100 %id)
BI489778 pooled brain, lung, testis .d 539 to 1223 1 to 688   AAA   688/688
(100 %)
6 diff
(99.2 %id)
BI760110 pooled colon, kidney, stomach .d 539 to 1128 1 to 596       596/989
(60 %)
11 diff
(98.9 %id)
BQ437550 eye, retinoblastoma .d 539 to 1223 1 to 685   AAA   685/685
(100 %)
0 diff
(100 %id)
BF974013 leiomyosarcoma cell line, uterus .d 540 to 1172 2 to 634       633/634
(99 %)
1 diff
(99.9 %id)
BG029377 breast, mammary adenocarcinoma, cell line .d 540 to 1225 1 to 695       695/707
(98 %)
18 diff
(97.5 %id)
C15569   .d 541 to 902 1 to 361       361/361
(100 %)
4 diff
(98.9 %id)
CN368304 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 541 to 1174 1 to 634       634/634
(100 %)
0 diff
(100 %id)
CN368310 embryonic stem cells, DMSO-treated H9 cellline .d 541 to 961 1 to 423       423/423
(100 %)
2 diff
(99.6 %id)
D60065   .d 541 to 922 1 to 375   fully sequenced,   375/375
(100 %)
5 diff
(98.7 %id)
D81195 brain .d 541 to 831 1 to 290       290/291
(99 %)
4 diff
(98.7 %id)
BM905240 melanotic melanoma, skin .d 541 to 1222 1 to 687       687/1092
(62 %)
6 diff
(99.5 %id)
BM424017 amelanotic melanoma, cell line, skin .d 542 to 1225 5 to 687       683/687
(99 %)
1 diff
(99.9 %id)
CA942897 Pancreas, Purified pancreatic islet .d 542 to 1002 1 to 461   fully sequenced,   461/461
(100 %)
0 diff
(100 %id)
BM701934 eye, optic nerve .d 542 to 1160 4 to 621       618/621
(99 %)
2 diff
(99.7 %id)
AA178867 muscle, skeletal muscle .d 543 to 951 1 to 405       405/405
(100 %)
15 diff
(96.3 %id)
BQ433305 epithelioid carcinoma, Pancreas .d 543 to 1223 1 to 681   AAA   681/681
(100 %)
0 diff
(100 %id)
CN368306 embryonic stem cells, DMSO-treated H9 cellline .d 544 to 1175 1 to 632       632/632
(100 %)
0 diff
(100 %id)
AA082231   .d 544 to 777 1 to 239   fully sequenced,   239/239
(100 %)
7 diff
(97.1 %id)
BE275648 melanotic melanoma, skin .d 544 to 1097 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BU543535 carcinoma, cell line, Prostate .d 545 to 1152 5 to 620       616/984
(62 %)
17 diff
(98.3 %id)
TI_1948217205   .d 545 to 992 574 to 127       448/1382
(32 %)
4 diff
(99.8 %id)
BE787157 large cell carcinoma, lung .d 548 to 1037 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CN368308 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 549 to 1052 1 to 504       504/504
(100 %)
0 diff
(100 %id)
CA312608 Human Lung Epithelial cells, lung .d 549 to 1223 693 to 19   AAA   675/682
(98 %)
0 diff
(100 %id)
AJ711347 heart .d 550 to 903 13 to 366       354/366
(96 %)
7 diff
(98.1 %id)
AJ714539 bone marrow .d 550 to 813 31 to 294       264/294
(89 %)
6 diff
(98.0 %id)
CN368303 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 550 to 1216 29 to 695       667/695
(95 %)
6 diff
(99.2 %id)
EC575184 Prostate .d 550 to 648 18 to 115       98/115
(85 %)
6 diff
(94.8 %id)
BE293854 adenocarcinoma cell line, colon .d 550 to 1164 620 to 4       617/631
(97 %)
5 diff
(99.3 %id)
BQ021306 lung, Metastatic Chondrosarcoma .d 550 to 1222 691 to 19   AAA   673/675
(99 %)
4 diff
(99.5 %id)
BM991737 Bone, Subchondral Bone .d 550 to 1223 693 to 19   AAA   675/689
(97 %)
2 diff
(99.8 %id)
BQ776996 Pancreas, Purified pancreatic islet .d 550 to 961 27 to 438   fully sequenced,   412/438
(94 %)
6 diff
(98.7 %id)
BU528161 epidermoid carcinoma, cell line, lung .d 550 to 1223 48 to 722       675/757
(89 %)
17 diff
(97.8 %id)
AU100041   .d 550 to 810 40 to 300       261/300
(87 %)
6 diff
(98.0 %id)
TI_154046937   .d 550 to 1223 772 to 98   AAA   675/997
(67 %)
1 diff
(99.9 %id)
TI_154190854   .d 550 to 1223 60 to 736   AAA   677/686
(98 %)
7 diff
(99.0 %id)
TI_227715770   .d 550 to 1223 814 to 142   AAA   673/939
(71 %)
34 diff
(96.4 %id)
CA312689 Human Lung Epithelial cells, lung .d 550 to 1223 693 to 19   AAA   675/688
(98 %)
1 diff
(99.9 %id)
BU625822 cell lines, Enchondroma .d 550 to 1223 695 to 19   AAA   677/693
(97 %)
3 diff
(99.6 %id)
CB529949 Aveolar Macrophage, lung .d 550 to 1223 692 to 19   AAA   674/676
(99 %)
2 diff
(99.8 %id)
TI_153951289   .d 550 to 1225 32 to 708   fully sequenced,   677/708
(95 %)
10 diff
(98.6 %id)
BE278766 choriocarcinoma, placenta .d 552 to 1210 1 to 653       653/656
(99 %)
7 diff
(99.0 %id)
CA312513 Human Lung Epithelial cells, lung .d 552 to 1223 690 to 19   AAA   672/688
(97 %)
0 diff
(100 %id)
BM691111 eye, RPE and Choroid .d 553 to 901 8 to 359   fully sequenced,   352/359
(98 %)
6 diff
(98.4 %id)
BM700407 eye, lens .d 553 to 752 1 to 200   fully sequenced,   200/200
(100 %)
0 diff
(100 %id)
BU615900 Bone, Subchondral Bone .d 553 to 1228 692 to 19   tiling clone, AAA   674/674
(100 %)
2 diff
(99.8 %id)
BE798917 lung, small cell carcinoma .d 554 to 1223 7 to 679   AAA   673/679
(99 %)
10 diff
(98.6 %id)
BG281971 melanotic melanoma, skin .d 556 to 1225 1 to 670       670/882
(75 %)
2 diff
(99.8 %id)
AA377430 synovial membrane .d 557 to 767 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
BE385476 melanotic melanoma, skin .d 557 to 1223 1 to 664   AAA   664/664
(100 %)
3 diff
(99.6 %id)
BG481088 choriocarcinoma, placenta .d 557 to 1161 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BF025704 melanotic melanoma, skin .d 558 to 1222 1 to 654   AAA   654/654
(100 %)
12 diff
(98.2 %id)
BG034491 breast, mammary adenocarcinoma, cell line .d 558 to 1223 1 to 665   AAA   665/665
(100 %)
1 diff
(99.9 %id)
AI832726 colon .d 559 to 1223 664 to 1       664/664
(100 %)
9 diff
(98.7 %id)
CN479058 Human Lung Epithelial cells, lung .d 559 to 1223 681 to 19   AAA   663/664
(99 %)
2 diff
(99.7 %id)
BE621034 epithelioid carcinoma, Pancreas .d 560 to 1225 1 to 658       658/699
(94 %)
12 diff
(98.3 %id)
CA412593 Chondrosarcoma Grade II, Left Pelvis .d 560 to 1223 683 to 19   AAA   665/665
(100 %)
1 diff
(99.9 %id)
BU624437 cell lines, Enchondroma .d 569 to 1223 674 to 19   AAA   656/656
(100 %)
1 diff
(99.9 %id)
CK820726 Pancreas, Purified pancreatic islet .d 570 to 1160 1 to 591     Submitted on the opposite strand 591/591
(100 %)
3 diff
(99.5 %id)
BU785214 Pancreas, Purified pancreatic islet .d 572 to 935 1 to 364   fully sequenced,   364/364
(100 %)
1 diff
(99.8 %id)
AI991273 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 574 to 1225 654 to 3       652/654
(99 %)
5 diff
(99.3 %id)
BG110862 Bone, osteosarcoma, cell line .d 574 to 1223 1 to 651   AAA   651/651
(100 %)
3 diff
(99.6 %id)
BM996729 lung, Metastatic Chondrosarcoma .d 576 to 1223 667 to 19   AAA   649/652
(99 %)
1 diff
(99.9 %id)
AI091611 parathyroid gland, parathyroid tumor .d 577 to 1220 644 to 1       644/644
(100 %)
4 diff
(99.4 %id)
BM272015 Pancreas, Purified pancreatic islet .d 581 to 1059 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
BE621653 epithelioid carcinoma, Pancreas .d 584 to 1191 618 to 2       617/618
(99 %)
10 diff
(98.4 %id)
CA947089 Pancreas, Purified pancreatic islet .d 586 to 936 1 to 351   fully sequenced,   351/351
(100 %)
0 diff
(100 %id)
AI310148 2 pooled tumors (clear cell type), Kidney .d 595 to 1225 635 to 4       632/635
(99 %)
9 diff
(98.6 %id)
BQ446993 Knee, Osteoarthritic Cartilage .d 603 to 1223 641 to 19   AAA   623/623
(100 %)
4 diff
(99.4 %id)
CD368964 Alveolar Macrophage, lung .d 603 to 1223 639 to 19   AAA   621/621
(100 %)
0 diff
(100 %id)
BG476925 melanotic melanoma, skin .d 604 to 1223 1 to 620   AAA   620/620
(100 %)
1 diff
(99.9 %id)
T59280 lung .d 610 to 906 45 to 344   fully sequenced,   300/344
(87 %)
9 diff
(97.4 %id)
AW884205 ovary .d 611 to 937 1 to 331       331/333
(99 %)
15 diff
(95.5 %id)
BU076278 Pancreas, Purified pancreatic islet .d 613 to 1225 613 to 1       613/613
(100 %)
0 diff
(100 %id)
AA303488 aorta .d 615 to 1000 1 to 387       387/392
(98 %)
6 diff
(98.5 %id)
BF764150 colon_est .d 618 to 836 8 to 226       219/226
(96 %)
6 diff
(97.4 %id)
BF764979 colon_est .d 618 to 836 2 to 220       219/220
(99 %)
6 diff
(97.3 %id)
BF764982 colon_est .d 618 to 836 1 to 219       219/219
(100 %)
7 diff
(96.9 %id)
BF765381 colon_est .d 618 to 836 219 to 1     Submitted on the opposite strand 219/228
(96 %)
5 diff
(97.9 %id)
BU628155 Bone, Enchondroma cell line .d 618 to 1223 624 to 19   AAA   606/606
(100 %)
2 diff
(99.7 %id)
BU625579 cell lines, Enchondroma .d 618 to 1223 625 to 19   AAA   607/607
(100 %)
2 diff
(99.7 %id)
BF766027 colon_est .d 622 to 854 1 to 232       232/243
(95 %)
12 diff
(95.1 %id)
AI871362 anaplastic oligodendroglioma, brain .d 626 to 1225 617 to 20       598/619
(96 %)
10 diff
(98.4 %id)
BF765057 colon_est .d 631 to 836 1 to 206       206/206
(100 %)
1 diff
(99.6 %id)
BF765102 colon_est .d 631 to 836 1 to 206       206/206
(100 %)
2 diff
(99.1 %id)
BF765437 colon_est .d 631 to 853 1 to 222       222/236
(94 %)
7 diff
(97.1 %id)
BF765705 colon_est .d 631 to 838 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BF766202 colon_est .d 631 to 836 1 to 206       206/206
(100 %)
1 diff
(99.6 %id)
BF765073 colon_est .d 632 to 836 8 to 212       205/212
(96 %)
7 diff
(96.7 %id)
CX869153 embryonic stem .d 632 to 1223 622 to 31   fully sequenced, AAA   592/592
(100 %)
6 diff
(99.0 %id)
BU623597 cell lines, Enchondroma .d 633 to 1223 609 to 19   AAA   591/591
(100 %)
1 diff
(99.9 %id)
BU632171 cell lines, Chondrosarcoma .d 635 to 1223 608 to 19   AAA   590/590
(100 %)
1 diff
(99.9 %id)
BI712194 Pancreas, Purified pancreatic islet .d 637 to 1223 587 to 1       587/587
(100 %)
1 diff
(99.9 %id)
CB529786 Aveolar Macrophage, lung .d 637 to 1223 605 to 19   AAA   587/587
(100 %)
11 diff
(98.2 %id)
BE741662 adenocarcinoma cell line, ovary .d 640 to 1223 1 to 584   AAA   584/584
(100 %)
0 diff
(100 %id)
BG334702 melanotic melanoma, skin .d 640 to 1224 1 to 584       584/876
(66 %)
2 diff
(99.8 %id)
BE315427 adenocarcinoma cell line, ovary .d 641 to 1220 1 to 581       581/582
(99 %)
2 diff
(99.7 %id)
CK820727 Pancreas, Purified pancreatic islet .d 645 to 1223 599 to 21   AAA Submitted on the opposite strand 579/579
(100 %)
0 diff
(100 %id)
AW516587 cervix, tumor .d 646 to 1223 578 to 1       578/578
(100 %)
2 diff
(99.7 %id)
BQ447013 Knee, Osteoarthritic Cartilage .d 648 to 1223 595 to 19   AAA   577/577
(100 %)
3 diff
(99.5 %id)
BU631842 cell lines, Chondrosarcoma .d 650 to 1223 591 to 19   AAA   573/573
(100 %)
2 diff
(99.7 %id)
BM271698 Pancreas, Purified pancreatic islet .d 652 to 1222 571 to 1       571/571
(100 %)
1 diff
(99.9 %id)
AW027348 thymus, pooled .d 653 to 1223 570 to 1       570/575
(99 %)
9 diff
(98.5 %id)
AW466874 2 pooled tumors (clear cell type), Kidney .d 653 to 1225 575 to 3       573/690
(83 %)
37 diff
(94.7 %id)
BG236243 blood, lymphocyte .d 655 to 1225 576 to 6       571/576
(99 %)
1 diff
(99.9 %id)
AI697386 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 658 to 1224 567 to 1       567/567
(100 %)
3 diff
(99.5 %id)
TI_157609677   .d 658 to 1223 679 to 114   AAA   566/566
(100 %)
4 diff
(99.3 %id)
R81763 placenta .d 659 to 1103 1 to 452       452/455
(99 %)
11 diff
(97.6 %id)
BG177992 adenocarcinoma, cell line, Prostate .d 659 to 1223 1 to 561   AAA   561/561
(100 %)
4 diff
(99.3 %id)
BM791906 Ascites, stomach .d 659 to 913 1 to 255       255/255
(100 %)
13 diff
(95.0 %id)
BE793919 lung, small cell carcinoma .d 661 to 1219 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
BP428740   .d 666 to 1026 1 to 361       361/361
(100 %)
3 diff
(99.2 %id)
CN368307 embryonic stem cells, DMSO-treated H9 cellline .d 674 to 1130 1 to 460       460/460
(100 %)
4 diff
(99.2 %id)
BF680325 Prostate .d 674 to 1032 360 to 1     Submitted on the opposite strand 360/373
(96 %)
1 diff
(99.8 %id)
BE185937 head_neck .d 677 to 1076 399 to 1     Submitted on the opposite strand 399/412
(96 %)
10 diff
(97.6 %id)
BU940508 mixed (pool of 40 RNAs) .d 679 to 1224 1 to 546       546/579
(94 %)
12 diff
(98.0 %id)
AA300622 testis .d 684 to 877 1 to 194       194/194
(100 %)
2 diff
(99.0 %id)
AW959459   .d 685 to 1223 1 to 542       542/662
(81 %)
32 diff
(95.2 %id)
AA845484 parathyroid gland, parathyroid tumor .d 686 to 1226 550 to 10       541/550
(98 %)
2 diff
(99.7 %id)
BI253076 hepatocellular carcinoma, cell line, Liver .d 691 to 1147 457 to 1   fully sequenced,   457/457
(100 %)
0 diff
(100 %id)
BM670523 eye, lens .d 691 to 1223 551 to 19   fully sequenced, AAA   533/533
(100 %)
0 diff
(100 %id)
BU738263 eye, lens .d 691 to 1223 551 to 19   fully sequenced, AAA   533/533
(100 %)
0 diff
(100 %id)
AI186808 lung .d 695 to 1214 520 to 1       520/520
(100 %)
2 diff
(99.7 %id)
AI435372 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 697 to 1228 534 to 3       532/534
(99 %)
0 diff
(100 %id)
AW088449 ovary, tumor, 5 pooled (see description) .d 697 to 1226 531 to 1       531/531
(100 %)
15 diff
(97.2 %id)
BM760641 lymph node, stomach .d 698 to 1007 1 to 310       310/310
(100 %)
0 diff
(100 %id)
BM840411 lymph node, stomach .d 698 to 1221 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
BM840214 lymph node, stomach .d 698 to 1223 1 to 526   AAA   526/526
(100 %)
1 diff
(99.9 %id)
BM704400 eye, RPE and Choroid .d 698 to 1223 1 to 526   AAA   526/526
(100 %)
2 diff
(99.7 %id)
BM704407 eye, RPE and Choroid .d 698 to 1225 1 to 528   fully sequenced,   528/528
(100 %)
1 diff
(99.9 %id)
BM782917 stomach .d 704 to 1225 1 to 522       522/528
(98 %)
1 diff
(99.9 %id)
AI346358 adenocarcinoma, colon .d 712 to 1223 537 to 25   AAA   513/513
(100 %)
15 diff
(97.1 %id)
BF843087 head_neck .d 714 to 877 14 to 177       164/177
(92 %)
1 diff
(99.5 %id)
BF337616 brain, glioblastoma with EGFR amplification .d 714 to 1223 1 to 508   AAA   508/508
(100 %)
2 diff
(99.7 %id)
AW390409 stomach .d 721 to 1130 412 to 3       410/450
(91 %)
3 diff
(99.4 %id)
AV708324 adrenal gland .d 722 to 1223 1 to 502   AAA   502/502
(100 %)
2 diff
(99.7 %id)
AI673234 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 723 to 1223 526 to 27   AAA   500/665
(75 %)
12 diff
(98.2 %id)
BE041198 lymph node, lymphoma, follicular mixed small and largecell .d 723 to 1223 515 to 14   AAA   502/516
(97 %)
13 diff
(97.5 %id)
AI868011 uterus .d 730 to 1223 507 to 14   AAA   494/494
(100 %)
1 diff
(99.8 %id)
BM792797 Ascites, stomach .d 731 to 1197 1 to 467       467/467
(100 %)
0 diff
(100 %id)
AV748522 Pituitary .d 732 to 1049 1 to 314       314/320
(98 %)
11 diff
(96.6 %id)
BM988505 lung, Metastatic Chondrosarcoma .d 735 to 1223 507 to 19   AAA   489/489
(100 %)
8 diff
(98.4 %id)
AI564444 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 738 to 1225 491 to 4       488/496
(98 %)
0 diff
(100 %id)
AA653927   .d 745 to 1122 1 to 376       376/376
(100 %)
8 diff
(97.9 %id)
AA101059   .d 747 to 1214 467 to 1   fully sequenced,   467/467
(100 %)
6 diff
(98.8 %id)
AA449103   .d 748 to 1224 481 to 6       476/481
(98 %)
4 diff
(99.2 %id)
BF081998 amnion_normal .d 751 to 1064 345 to 32       314/345
(91 %)
4 diff
(98.9 %id)
AJ574478 pectoral muscle (after mastectomy) .d 753 to 1181 1 to 430       430/430
(100 %)
9 diff
(98.0 %id)
AA627999 colon, colon tumor RER+ .d 754 to 1223 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
AI494459 anaplastic oligodendroglioma, brain .d 757 to 1223 467 to 1       467/467
(100 %)
1 diff
(99.8 %id)
AI094561 brain, glioblastoma (pooled) .d 759 to 1223 484 to 23   AAA   462/462
(100 %)
7 diff
(98.5 %id)
AA534243 invasive prostate tumor, Prostate .d 763 to 1223 1 to 460   AAA   460/460
(100 %)
15 diff
(96.8 %id)
BE714820 head_neck .d 766 to 1076 331 to 22       310/331
(93 %)
4 diff
(98.8 %id)
DB539822 hippocampus .d 768 to 1222 1 to 460     Submitted on the opposite strand 460/460
(100 %)
8 diff
(98.3 %id)
AA961899 pooled germ cell tumors .d 768 to 1225 456 to 4       453/456
(99 %)
8 diff
(98.3 %id)
BM991582 Bone, Subchondral Bone .d 769 to 1223 474 to 19   AAA   456/456
(100 %)
6 diff
(98.7 %id)
AA872780 2 pooled tumors (clear cell type), Kidney .d 770 to 1225 451 to 4       448/451
(99 %)
9 diff
(98.1 %id)
AW410921 muscle, rhabdomyosarcoma .d 771 to 1223 504 to 52   fully sequenced, AAA   453/453
(100 %)
3 diff
(99.4 %id)
BU730561 eye, RPE and Choroid .d 771 to 1223 471 to 19   fully sequenced, AAA   453/453
(100 %)
1 diff
(99.8 %id)
BE715870 head_neck .d 772 to 1119 357 to 9       349/584
(59 %)
7 diff
(98.9 %id)
BE715841 head_neck .d 781 to 1120 354 to 12       343/359
(95 %)
5 diff
(98.7 %id)
BE715820 head_neck .d 790 to 1122 21 to 363       343/374
(91 %)
22 diff
(94.2 %id)
BE715810 head_neck .d 791 to 1127 11 to 345       335/346
(96 %)
14 diff
(96.0 %id)
F24950 pectoral muscle (after mastectomy) .d 793 to 1223 1 to 429       429/429
(100 %)
7 diff
(98.4 %id)
AW796983 uterus .d 798 to 916 123 to 8       116/124
(93 %)
8 diff
(93.6 %id)
BE836266 prostate_normal .d 798 to 1127 29 to 357       329/358
(91 %)
11 diff
(97.0 %id)
BE843965 testis_normal .d 798 to 1058 7 to 267       261/267
(97 %)
7 diff
(97.4 %id)
AI922237 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 798 to 1225 430 to 3       428/436
(98 %)
1 diff
(99.8 %id)
T60888 ovary .d 799 to 1088 1 to 293       293/300
(97 %)
13 diff
(95.7 %id)
AA156322 Pancreas .d 799 to 1214 414 to 1       414/414
(100 %)
4 diff
(99.1 %id)
AA535885 colon .d 799 to 1214 413 to 1       413/549
(75 %)
4 diff
(99.3 %id)
AA176403 muscle, skeletal muscle .d 800 to 1206 409 to 1       409/454
(90 %)
12 diff
(97.4 %id)
DB561260 hypothalamus .d 802 to 1226 1 to 426     Submitted on the opposite strand 426/428
(99 %)
4 diff
(99.1 %id)
AA931989 Kidney .d 803 to 1224 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
BE697300 colon .d 807 to 1215 1 to 407       407/407
(100 %)
7 diff
(98.3 %id)
N63252 multiple sclerosis lesions .d 814 to 1223 411 to 1       411/417
(98 %)
3 diff
(99.3 %id)
BF092214 testis_normal .d 816 to 1058 16 to 253       238/253
(94 %)
6 diff
(97.7 %id)
AA493835 thyroid .d 816 to 1223 426 to 20   AAA   407/407
(100 %)
5 diff
(98.8 %id)
AI167407 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 816 to 1224 405 to 1       405/410
(98 %)
4 diff
(99.1 %id)
AI290344 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 819 to 1223 407 to 1       407/417
(97 %)
2 diff
(99.6 %id)
BE908095 epithelioid carcinoma, Pancreas .d 819 to 1225 1 to 407   AAA   407/420
(96 %)
2 diff
(99.6 %id)
CR738302   .d 821 to 1223 1 to 403   AAA   403/403
(100 %)
0 diff
(100 %id)
AI149938   .d 822 to 1225 408 to 5       404/408
(99 %)
0 diff
(100 %id)
AI459901 colon .d 824 to 1225 403 to 2       402/403
(99 %)
0 diff
(100 %id)
BF445867 Prostate .d 824 to 1225 409 to 7       403/409
(98 %)
3 diff
(99.3 %id)
BQ012553 placenta .d 828 to 1223 414 to 19   AAA   396/396
(100 %)
0 diff
(100 %id)
AI224169 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 829 to 1223 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
AI283251 adenocarcinoma, colon .d 829 to 1225 403 to 7       397/403
(98 %)
1 diff
(99.8 %id)
AI280465 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 829 to 1223 418 to 23   AAA   396/399
(99 %)
14 diff
(96.5 %id)
AI268217 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 829 to 1223 424 to 29   AAA   396/396
(100 %)
19 diff
(95.3 %id)
AA452235   .d 832 to 1225 396 to 2       395/396
(99 %)
0 diff
(100 %id)
AA629884 lung, lung carcinoma .d 832 to 1216 384 to 1       384/386
(99 %)
1 diff
(99.8 %id)
AA829857 germinal center B cell .d 832 to 1223 402 to 11   AAA   392/392
(100 %)
0 diff
(100 %id)
AI334119 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 832 to 1223 392 to 1       392/392
(100 %)
2 diff
(99.5 %id)
AA417952.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 833 to 1224 393 to 1     also hits gene TPBG 393/393
(100 %)
1 diff
(99.8 %id)
AA826419 carcinoid, lung .d 833 to 1225 394 to 2       393/394
(99 %)
0 diff
(100 %id)
BF736001 bladder_tumor .d 835 to 1225 394 to 4     Submitted on the opposite strand 391/394
(99 %)
0 diff
(100 %id)
AA888036 colon, colon tumor RER+ .d 843 to 1214 372 to 1       372/372
(100 %)
2 diff
(99.5 %id)
AI869562 anaplastic oligodendroglioma, brain .d 846 to 1214 372 to 1       372/372
(100 %)
13 diff
(96.6 %id)
AA293807 ovarian tumor, ovary .d 848 to 1224 377 to 1   fully sequenced,   377/377
(100 %)
0 diff
(100 %id)
AI950651 lung, two pooled squamous cell carcinomas .d 850 to 1223 381 to 1       381/381
(100 %)
11 diff
(97.2 %id)
BX369150 Placenta Cot 25-normalized .d 851 to 1225 1 to 374       374/374
(100 %)
1 diff
(99.8 %id)
BF880511 lung_tumor .d 858 to 1068 218 to 10     Submitted on the opposite strand 209/222
(94 %)
0 diff
(100 %id)
BF845162 head_neck .d 859 to 1090 1 to 232       232/232
(100 %)
0 diff
(100 %id)
AI261436 Kidney .d 859 to 1225 368 to 2       367/368
(99 %)
3 diff
(99.2 %id)
AA412722   .d 861 to 1223 399 to 37   AAA   363/363
(100 %)
0 diff
(100 %id)
AA614755 breast .d 870 to 1223 372 to 19   AAA   354/354
(100 %)
3 diff
(99.2 %id)
BM663591 eye, RPE and Choroid .d 871 to 1223 370 to 18   fully sequenced, AAA   353/353
(100 %)
1 diff
(99.8 %id)
TI_151736116   .d 871 to 1223 489 to 137   fully sequenced, AAA   353/353
(100 %)
1 diff
(99.8 %id)
AI001202 pooled germ cell tumors .d 874 to 1225 360 to 9       352/360
(97 %)
3 diff
(99.2 %id)
AI446593 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 875 to 1223 349 to 1       349/349
(100 %)
0 diff
(100 %id)
T59239 lung .d 876 to 1225 353 to 2   fully sequenced,   352/353
(99 %)
3 diff
(99.2 %id)
AI917148 Kidney, renal cell tumor .d 877 to 1225 350 to 2       349/350
(99 %)
0 diff
(100 %id)
AI040094   .d 880 to 1223 358 to 15   AAA   344/344
(100 %)
13 diff
(96.3 %id)
AA424408   .d 883 to 1225 345 to 4   fully sequenced,   342/345
(99 %)
0 diff
(100 %id)
CF529967 placenta .d 891 to 1223 351 to 19   AAA   333/333
(100 %)
0 diff
(100 %id)
D60064   .d 892 to 1220 328 to 1   fully sequenced,   328/328
(100 %)
3 diff
(99.1 %id)
AA077416 brain .d 896 to 1188 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AA077688 brain .d 896 to 1146 1 to 251       251/251
(100 %)
1 diff
(99.7 %id)
G30691   .d 896 to 1188 293 to 1     Submitted on the opposite strand 293/293
(100 %)
0 diff
(100 %id)
BU784954 Pancreas, Purified pancreatic islet .d 905 to 1222 318 to 1   fully sequenced,   318/318
(100 %)
2 diff
(99.4 %id)
CA946814 Pancreas, Purified pancreatic islet .d 906 to 1222 317 to 1   fully sequenced,   317/317
(100 %)
0 diff
(100 %id)
AI198151 anaplastic oligodendroglioma, brain .d 913 to 1225 318 to 5       314/318
(98 %)
1 diff
(99.7 %id)
T56280 Liver .d 918 to 1205 293 to 1       293/362
(80 %)
6 diff
(98.4 %id)
N53424 multiple sclerosis lesions .d 920 to 1223 306 to 1       306/306
(100 %)
3 diff
(99.1 %id)
AA809965 germinal center B cell .d 923 to 1223 312 to 12   AAA   301/301
(100 %)
0 diff
(100 %id)
N93827.
matches multiple genes
lung .d 924 to 1223 301 to 1     also hits gene SF3B1 301/301
(100 %)
2 diff
(99.4 %id)
N53748 multiple sclerosis lesions .d 930 to 1137 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BU069259 Pancreas, Purified pancreatic islet .d 931 to 1222 292 to 1   fully sequenced,   292/292
(100 %)
0 diff
(100 %id)
CA942657 Pancreas, Purified pancreatic islet .d 941 to 1223 283 to 1   fully sequenced,   283/283
(100 %)
0 diff
(100 %id)
BM672933 eye, optic nerve .d 941 to 1223 301 to 19   fully sequenced, AAA   283/283
(100 %)
0 diff
(100 %id)
FN073483 breast carcinoma .d 948 to 1050 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
AA506542 Liver .d 952 to 1223 297 to 26   AAA   272/272
(100 %)
0 diff
(100 %id)
BI256601 cervical carcinoma cell line, cervix .d 969 to 1223 16 to 269   AAA   254/269
(94 %)
6 diff
(97.8 %id)
EC558762 Prostate .d 976 to 1070 1 to 95       95/95
(100 %)
0 diff
(100 %id)
AI280449 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 982 to 1223 264 to 23   AAA   242/242
(100 %)
3 diff
(98.8 %id)
N32065 placenta .d 985 to 1230 247 to 2       246/365
(67 %)
5 diff
(98.7 %id)
AI417955 Prostate .d 986 to 1225 244 to 5       240/244
(98 %)
0 diff
(100 %id)
BU589031 mixed (pool of 40 RNAs) .d 986 to 1222 1 to 237       237/273
(86 %)
2 diff
(99.3 %id)
AA888038 colon, colon tumor RER+ .d 987 to 1214 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AI201890 Prostate .d 994 to 1225 232 to 1       232/232
(100 %)
0 diff
(100 %id)
AA876773 metastatic prostate bone lesion .d 995 to 1222 1 to 227   AAA   227/227
(100 %)
3 diff
(98.7 %id)
F34036 pectoral muscle (after mastectomy) .d 1000 to 1212 1 to 210       210/210
(100 %)
8 diff
(96.2 %id)
BE170948 head_neck .d 1001 to 1189 1 to 191       191/191
(100 %)
3 diff
(98.5 %id)
AI352704 pooled germ cell tumors .d 1023 to 1223 201 to 1       201/201
(100 %)
0 diff
(100 %id)
BE466734 pooled germ cell tumors .d 1023 to 1223 201 to 1       201/201
(100 %)
0 diff
(100 %id)
FN129619 breast carcinoma .d 1060 to 1158 104 to 2     Submitted on the opposite strand 103/105
(98 %)
0 diff
(100 %id)
BQ946263 leiomyosarcoma, uterus .d 1081 to 1223 1 to 142   AAA   142/142
(100 %)
1 diff
(99.3 %id)
T25146   .d 1095 to 1224 132 to 3       130/132
(98 %)
0 diff
(100 %id)
FN157398 breast carcinoma .d 1101 to 1160 62 to 1     Submitted on the opposite strand 62/62
(100 %)
2 diff
(96.8 %id)
AL704209 human skeletal muscle .e-u 1 to 622 10 to 632   tiling clone,   623/623
(100 %)
7 diff
(98.9 %id)
CN315380 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e-u 51 to 779 1 to 730 D114R V115R A116G S117I S118* tiling clone,   730/730
(100 %)
3 diff
(99.6 %id)
CF137963 lymph .e-u 117 to 656 8 to 547       540/547
(98 %)
6 diff
(99.0 %id)
TI_154167679   .e-u 117 to 692 80 to 662       583/888
(65 %)
12 diff
(98.7 %id)
AA132664 colon, tumor .f 1 to 360 1 to 363   tiling clone, fully sequenced,   363/363
(100 %)
10 diff
(97.3 %id)
AA132541 colon, tumor .f 351 to 792 442 to 1   tiling clone, fully sequenced,   442/442
(100 %)
6 diff
(98.7 %id)
BG334004 melanotic melanoma, skin .g 1 to 752 1 to 752 A2R L4V L56T P57A Q58S ... tiling clone,   752/858
(87 %)
34 diff
(96.1 %id)
BI771874 pooled lung and spleen .h 1 to 857 1 to 874 exact tiling clone,   800/933
(85 %)
42 diff
(95.5 %id)
TI_57179610   .h 1 to 857 34 to 907 exact     800/966
(82 %)
48 diff
(95.1 %id)
CX752060 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 1 to 708 1 to 700 exact tiling clone, Submitted on the opposite strand 700/823
(85 %)
11 diff
(98.7 %id)
CX755753 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 1 to 709 1 to 701 Q12R S31N F47L G48S P64A ... AAA Submitted on the opposite strand 701/701
(100 %)
27 diff
(96.2 %id)
BE731559 choriocarcinoma, placenta .i 40 to 709 1 to 665 L24W L26*     665/674
(98 %)
8 diff
(98.9 %id)
BE311538 Kidney, renal cell adenocarcinoma .i 45 to 705 1 to 657 P64R A65Q A66R S67R H68I ...     657/658
(99 %)
5 diff
(99.3 %id)
CN368309 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 99 to 604 1 to 506       506/506
(100 %)
4 diff
(99.3 %id)
BM818577 stomach .i 284 to 589 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
BU588577 mixed (pool of 40 RNAs) .i 481 to 704 1 to 224   tiling clone, AAA   224/224
(100 %)
2 diff
(99.2 %id)
DA132279 alzheimer cortex .j 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
3 diff
(99.5 %id)
DA947414 Spleen .j 1 to 595 2 to 596 R14A S15D Q16L L17S A18S ... tiling clone, capped   595/595
(100 %)
7 diff
(98.9 %id)
BM825886 Ascites, stomach .j 12 to 412 1 to 400 exact     400/400
(100 %)
5 diff
(98.8 %id)
BI770875 pooled lung and spleen .j 40 to 500 1 to 459       459/955
(48 %)
12 diff
(98.8 %id)
AF093571   Gene ZNHIT1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AV693703 hepatocellular carcinoma Gene ZNHIT1, variant not shown         Suspected internal deletion, this clone was ignored    
AV693557 hepatocellular carcinoma Gene ZNHIT1, variant not shown         Suspected internal deletion, this clone was ignored    
BE208515.
matches multiple genes
lung, small cell carcinoma Gene sworskaby, variant not shown         This clone was ignored, also hits gene sworskaby    
BE208515.
matches multiple genes
lung, small cell carcinoma Gene ZNHIT1, variant not shown         This clone was ignored, also hits gene sworskaby    
AW732131.
matches multiple genes
lung, small cell carcinoma Gene sworskaby, variant not shown         This clone was ignored, also hits gene sworskaby    
AW732131.
matches multiple genes
lung, small cell carcinoma Gene ZNHIT1, variant not shown         This clone was ignored, also hits gene sworskaby    
BP341606 stomach mucosa Gene ZNHIT1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI